Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers

IMPORTANCE: Novel plasma biomarkers, especially phosphorylated tau (p-tau), can detect brain tau aggregates in Alzheimer disease. OBJECTIVE: To determine which plasma biomarker combinations can accurately detect tau pathological brain changes in Down syndrome (DS). DESIGN, SETTING, AND PARTICIPANTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Janelidze, Shorena, Christian, Bradley T., Price, Julie, Laymon, Charles, Schupf, Nicole, Klunk, William E., Lott, Ira, Silverman, Wayne, Rosas, H. Diana, Zaman, Shahid, Mapstone, Mark, Lai, Florence, Ances, Beau M., Handen, Benjamin L., Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257682/
https://www.ncbi.nlm.nih.gov/pubmed/35789365
http://dx.doi.org/10.1001/jamaneurol.2022.1740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257682/
https://www.ncbi.nlm.nih.gov/pubmed/35789365
http://dx.doi.org/10.1001/jamaneurol.2022.1740

Ejemplares similares